Publications

Basso AD, Solit DB, Munster PN, Rosen N. Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2. Oncogene. 2002. PMID: 11850835

Harmon EB, Ko AH, Kim SK. Hedgehog signaling in gastrointestinal development and disease. Volume 2 of Issue 1 Current molecular medicine. 2002. PMID: 11898849

Linker CA, Damon LE, Ries CA, Navarro WA, Case D, Wolf JL. Autologous stem cell transplantation for advanced acute myeloid leukemia. Bone marrow transplantation. 2002. PMID: 11896426

Oh WK, Small EJ. PC-SPES and prostate cancer. The Urologic clinics of North America. 2002. PMID: 12109356

Lee SR, Ramos SM, Ko A, Masiello D, Swanson KD, Lu ML, Balk SP. AR and ER interaction with a p21-activated kinase (PAK6). Volume 16 of Issue 1 Molecular endocrinology (Baltimore, Md.). 2002. PMID: 11773441

Komanduri KV. Thymic function and allogeneic T-cell responses in stem-cell transplantation. Cytotherapy. 2002. PMID: 12396833

Augustine SC, Norenberg JP, Colcher DM, Vose JM, Gobar LS, Dukat VJ, Hohenstein MA, Rutar FJ, Jacobson DA, Tempero MA. Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice. Journal of the American Pharmaceutical Association (Washington, D.C. : 1996). 2002. PMID: 11833524

Gordan JD, Vonderheide RH. Universal tumor antigens as targets for immunotherapy. Cytotherapy. 2002. PMID: 12396831

Fong L, Brockstedt D, Benike C, Breen JK, Strang G, Ruegg CL, Engleman EG. Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy. Journal of immunology (Baltimore, Md. : 1950). 2001. PMID: 11739538

Patterson S, Ko A, O'Connell TX. Radiation after mastectomy in high-risk patients: is it necessary? Volume 67 of Issue 12 The American surgeon. 2001. PMID: 11768832

Gordon KB, Rugo HS, Duncan JL, Irvine AR, Howes EL, O'Brien JM, Carter SR. Ocular manifestations of leukemia: leukemic infiltration versus infectious process. Ophthalmology. 2001. PMID: 11733273

Elfman F, Bok R, Conn M, Shuman M, Cunha G. Urokinase plasminogen activator amino-terminal peptides inhibit development of the rat ventral prostate. Differentiation; research in biological diversity. 2001. PMID: 11798065

Munster PN, Troso-Sandoval T, Rosen N, Rifkind R, Marks PA, Richon VM. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer research. 2001. PMID: 11731433

Fornier MN, Seidman AD, Theodoulou M, Moynahan ME, Currie V, Moasser M, Sklarin N, Gilewski T, D'Andrea G, Salvaggio R, Panageas KS, Norton L, Hudis C. Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001. PMID: 11751485

Sayre PH, Finer-Moore JS, Fritz TA, Biermann D, Gates SB, MacKellar WC, Patel VF, Stroud RM. Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases. Volume 313 of Issue 4 Journal of molecular biology. 2001. PMID: 11697906

Munster PN, Horton J. Tamoxifen vs the aromatase inhibitors: news from San Antonio, 2001. Cancer control : journal of the Moffitt Cancer Center. 2001. PMID: 11807416

Ortiz GM, Wellons M, Brancato J, Vo HT, Zinn RL, Clarkson DE, Van Loon K, Bonhoeffer S, Miralles GD, Montefiori D, Bartlett JA, Nixon DF. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proceedings of the National Academy of Sciences of the United States of America. 2001. PMID: 11687611

Moasser MM, Basso A, Averbuch SD, Rosen N. The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells. Cancer research. 2001. PMID: 11585753

Munster PN, Norton L. Predictive factor for the response to adjuvant therapy with emphasis in breast cancer. Breast cancer research : BCR. 2001. PMID: 11737886

Bergsland EK. Molecular mechanisms underlying the development of hepatocellular carcinoma. Seminars in oncology. 2001. PMID: 11685745